Insulin Glargine vs Yttrium Y 90 Ibritumomab Tiuxetan
Insulin Glargine vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview
This comparison examines the pharmacological differences between Insulin Glargine and Yttrium Y 90 Ibritumomab Tiuxetan.
Mechanism of Action
Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.
Pharmacokinetics
Half-life: Insulin Glargine β 12-24 hours.
Chemical Properties
Type: Insulin Glargine β Protein; Yttrium Y 90 Ibritumomab Tiuxetan β Antibody.